The stock market’s midday trading reflects a stark divide between winners and losers, underscoring the capricious nature of current economic conditions. Notably, Boeing has emerged victorious, witnessing a nearly 5% surge in its shares following President Trump’s decision to award them a crucial contract for the next-generation fighter jet. This move highlights Boeing’s persistent ability
The landscape of pharmaceuticals is witnessing an upheaval, particularly in the realm of weight-loss and diabetes medications. Compounding pharmacies have historically filled gaps where traditional drug manufacturers fall short, but recent regulatory changes threaten to disrupt this intricate ecosystem. With Eli Lilly’s weight-loss drug Zepbound and diabetes drug Mounjaro officially out of shortage status, compounding
Darden Restaurants recently unveiled its third-quarter earnings, which painted a picture of tempered growth and cautious optimism. The restaurant conglomerate, home to well-known brands like Olive Garden and LongHorn Steakhouse, reported earnings of $2.80 per share, slightly eclipsing the Wall Street expectations of $2.79. However, the bright spot in the earnings report dimmed under the
In a world increasingly governed by technology, the announcement of a $25 billion investment partnership between the Abu Dhabi sovereign wealth fund ADQ and American private equity firm Energy Capital Partners (ECP) signifies a monumental shift in global power dynamics. This deal, aimed at addressing the soaring electricity demands of data centers and other energy-intensive